Movers
calendar_month Mar 21, 2024

12 Health Care Stocks Moving In Thursday’s Pre-Market Session

Gainers

  • Yield10 Bioscience (NASDAQ:YTEN) stock increased by 133.7% to $0.57 during Thursday’s pre-market session. The market value of their outstanding shares is at $6.8 million.
  • Immunovant (NASDAQ:IMVT) shares moved upwards by 14.0% to $35.99. The market value of their outstanding shares is at $5.2 billion.
  • argenx (NASDAQ:ARGX) stock moved upwards by 13.24% to $404.22. The market value of their outstanding shares is at $23.9 billion.
  • Virios Therapeutics (NASDAQ:VIRI) shares moved upwards by 11.79% to $0.39. The company’s market cap stands at $7.5 million.
  • Aspira Womens Health (NASDAQ:AWH) stock rose 10.79% to $3.85. The company’s market cap stands at $39.7 million.
  • CareMax (NASDAQ:CMAX) stock moved upwards by 10.6% to $6.05. The market value of their outstanding shares is at $23.0 million. As per the press release, Q4 earnings came out 3 days ago.

Losers

  • Tourmaline Bio (NASDAQ:TRML) shares decreased by 33.4% to $29.75 during Thursday’s pre-market session. The company’s market cap stands at $762.9 million. The company’s, Q4 earnings came out 2 days ago.
  • Apyx Medical (NASDAQ:APYX) stock fell 16.22% to $1.55. The company’s market cap stands at $53.6 million. The company’s, Q4 earnings came out today.
  • Immatics (NASDAQ:IMTX) shares declined by 15.49% to $10.18. The market value of their outstanding shares is at $1.0 billion.
  • Biophytis (NASDAQ:BPTS) stock declined by 13.43% to $0.38. The market value of their outstanding shares is at $4.4 million.
  • Exscientia (NASDAQ:EXAI) shares declined by 12.69% to $5.99. The company’s market cap stands at $748.3 million. As per the press release, Q4 earnings came out today.
  • Avinger (NASDAQ:AVGR) stock decreased by 12.43% to $2.89. The company’s market cap stands at $3.9 million. The company’s, Q4 earnings came out yesterday.
    See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga’s automated content engine and reviewed by an editor.